About
Resolute Science develops synthetic drug conjugates that target tumor-associated macrophages to deliver cytotoxic or radiotherapeutic agents to solid tumors, aiming to treat aggressive and treatment-resistant cancers.
Explore Resolute Science's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.